BGI Genomics (SHE:300676) posted third-quarter attributable net loss of 27.2 million yuan, widening 81% from the previous year.
Losses per share deepened 81% to 0.0653 yuan, according to a Friday filing with the Shenzhen bourse.
The genomics services provider's operating revenue climbed 9.2% year over year to 1.04 billion yuan.